◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Tong Ren Tang Technologies Co. Ltd. (1666) Financial History

Name: Tong Ren Tang Technologies Co. Ltd. (1666) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Tong Ren Tang Technologies Co. Ltd. (1666) operates in the Drug Manufacturers - General industry and is headquartered in Beijing, China with about 3,951 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 1666 reported CNY 6.5B in revenue and CNY 396M in net income.

Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through three segments: The Company; Tong Ren Tang Chinese Medicine; and Others.

Interactive charts & full statements →

1666 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 6.5B	CNY 7.3B	CNY 6.8B	CNY 6.0B	—
Gross Profit	CNY 2.5B	CNY 2.9B	CNY 2.8B	CNY 2.6B	—
Operating Income (EBIT)	CNY 802M	CNY 985M	CNY 1.1B	CNY 1.2B	—
Net Income	CNY 396M	CNY 522M	CNY 590M	CNY 583M	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1666 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 228M)	(CNY 228M)	(CNY 203M)	(CNY 205M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1666 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 13.7B	CNY 14.4B	CNY 13.5B	CNY 12.5B	—
Total Liabilities	CNY 3.4B	CNY 4.2B	CNY 3.9B	CNY 3.5B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1666 viewer.

Other Companies in Drug Manufacturers - General

4552 · JCR Pharmaceuticals Co., Ltd. — $62 billion
BAYN · Bayer Aktiengesellschaft — $47 billion
2630 · Vigonvita Life Sciences Co., Ltd. — $20 billion
9637 · Alebund Pharmaceuticals (Jiangsu) Limited — $11 billion
OGN · Organon & Co. — $4 billion
VIRP · Virbac SA — $3 billion
1643 · Modern Chinese Medicine Group Co., Ltd. — $598 million
SCLX · Scilex Holding Company — $47 million

← 1663 All “0-9” companies 1667 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.